Human Pathology
Volume 41, Issue 6 , Pages 794-804 , June 2010

Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinoma

  • Mari Bunkholt Elstrand, MD

      Affiliations

    • Division of Obstetrics and Gynecology, Section for Gynecologic Oncology, Norwegian Radium Hospital, Oslo University Hospital, N-0310 Oslo, Norway
    • ,
  • Hiep Phuc Dong, MSc

      Affiliations

    • Division of Pathology, Norwegian Radium Hospital, Oslo University Hospital, N-0310 Oslo, Norway
    • ,
  • Elin Ødegaard, MD, PhD

      Affiliations

    • Division of Obstetrics and Gynecology, Section for Gynecologic Oncology, Norwegian Radium Hospital, Oslo University Hospital, N-0310 Oslo, Norway
    • ,
  • Arild Holth, BSc

      Affiliations

    • Division of Pathology, Norwegian Radium Hospital, Oslo University Hospital, N-0310 Oslo, Norway
    • ,
  • Sivan Elloul, MSc

      Affiliations

    • Department of Pharmacology and Experimental Therapeutics, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
    • ,
  • Reuven Reich, PhD

      Affiliations

    • Department of Pharmacology and Experimental Therapeutics, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel
    • ,
  • Claes G. Tropé, MD, PhD

      Affiliations

    • Division of Obstetrics and Gynecology, Section for Gynecologic Oncology, Norwegian Radium Hospital, Oslo University Hospital, N-0310 Oslo, Norway
    • Faculty Division Radiumhospitalet, the Medical Faculty, University of Oslo, N-0316 Oslo, Norway
    • ,
  • Ben Davidson, MD, PhD

      Affiliations

    • Division of Pathology, Norwegian Radium Hospital, Oslo University Hospital, N-0310 Oslo, Norway
    • Faculty Division Radiumhospitalet, the Medical Faculty, University of Oslo, N-0316 Oslo, Norway
    • Corresponding Author InformationCorresponding author. Department of Pathology, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, N-0310 Oslo, Norway.

Received 29 May 2009 ,Revised 28 August 2009 ,Accepted 22 September 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Financial acknowledgement: This work was supported by grants from the Norwegian Cancer Society (Olso, Norway), the Health Region of South-Eastern Norway (Hamar, Norway), and the Inger and Jon Fredriksen Foundation for Ovarian Cancer Research (Olso, Norway).

PII: S0046-8177(09)00426-2

doi: 10.1016/j.humpath.2009.09.017

Human Pathology
Volume 41, Issue 6 , Pages 794-804 , June 2010

Article Tools

* Image Usage & Resolution